A prospective study to investigate the impact of glucose variability using continuous glucose monitoring system on heart function in patients with type 2 diabetes.
- Conditions
- Endocrine, nutritional and metabolic diseases
Recruitment & Eligibility
- Status
- Withdrawn
- Sex
- All
- Target Recruitment
- 50
Patients with type 2 diabetes using insulin or insulin + oral hypoglycemic agents
- Men and women aged 19 to 75 years old
- >= 7.5% HbA1c at baseline
- A person who can measure his or her own blood glucose.
- A person who agrees to participate in this clinical trial and agrees in writing consent.
- Type 1 diabetes.
- Patients with severe renal insufficiency: eGFR < 30 ml/min
- Those who have been diagnosed with a previous coronary artery disease, cardiovascular surgery or stroke
- Person diagnosed with previous heart failure
- Person who has been diagnosed with a malignancy within the last five years and whose treatment has not been completed.
- Recipients of organ transplantation or long-term immunosuppressants
- Steroid user
- Pregnant or breastfeeding women
- A person who is deemed unfit to participate in a clinical trial by investigator
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of E/e' changes compared to control group
- Secondary Outcome Measures
Name Time Method Comparison of change in glycemic variability compared to control group;Comparison of change in HbA1c compared to control group;Comparison of development or progression of diabetic retinopathy compared to control group;Comparison of change in urine albumin-to-creatinine ratio compared to control group;Comparison of change in severe hypoglycemia compared to control group